Pharmaceutical Digital Marketing

Transforming your Multi-Channel Marketing Mix to Unlock Brand Value

Pharmaceutical Digital Marketing

$995.00

Develop digital marketing strategies that complement healthcare audiences’ increased digital presence.

  • Discover the right marketing mix, balancing traditional and digital approaches.
  • Determine resource levels needed in aligning digital marketing with brand/corporate team goals.
  • Orchestrate in-house capabilities and vendor expertise to make the most out of digital initiatives.
  • Description
  • Additional information

REPORT HIGHLIGHTS

Companies worldwide deploy social media platforms, mobile websites and mobile applications to reach their target audiences. These channels provide information on disease states, treatment options and branded products. Report findings focus on existing digital marketing budgets, structures and media mixes — including the extent to which companies use mobile applications and social media.

Pharmaceutical Digital Marketing: Transforming your Multi-Channel Marketing Mix to Unlock Brand Value

  • Publication Date: March 2014
  • Pages: 221
  • Chapters: 5 + an Exec. summary
  • 45+ participating companies
  • Charts/Graphics: 115+

Data has also been split by company size:

  • Top 20
  • Top 50
  • Small Pharma
  • Affiliate Pharma

Data has also been split by team type:

  • Brand Teams
  • Corporate Teams

Case studies and metrics detailing usage of and therapeutic area presence on social media platforms, including:

    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Vimeo

Digital team staffing profiles for:

  • Top 20 and affiliate
  • Top 50
  • Small pharma
  • Corporate/brand teamsourcing

Metrics explore companies’ marketing objectives, structures, budgets and marketing media mixes — including the extent to which companies use mobile applications and social media. Findings provide insight into companies’ evolving ROI strategies — including, specifically, the use of hard and soft metrics to showcase the potential value of new digital channels.

Report Features

This report will help marketing teams reinforce their digital marketing strategies. Indepth benchmarks explore companies’ digital marketing objectives, structures, budgets, and media mixes — including the extent to which companies use mobile applications and social media. It also provides insight into companies’ evolving ROI strategies; specifically, the use of hard and soft metrics to showcase the potential value of new digital channels.

Reason to Buy

In this day and age, virtually no one is without a cell phone nearby. Drug and device companies are investing frequently in mobile apps and social media channels to tap into our increasingly digital environment. Surveyed companies are using social media target patients. Furthermore, 80% of companies use mobile applications to target physicians. Stay ahead of the curve with the strategic recommendations and insights contained in this report. They will help you navigate current and future social media marketing and mobile application trends. The report includes benchmarks for companies’ annual media mixes from 2012 through 2014.

Target Audience

The primary audience for this study encompasses life science vice presidents, directors and managers who are part of commercialization teams, including:
– Marketing
– Digital marketing
– Multichannel marketing teams
– Brand management
– Customer strategy
– Media relations
– Product communications teams
– Product centers of excellence

Chapter Example

The landscape for pharmaceutical digital marketing is changing rapidly. But some companies still lag behind the curve when it comes to utilizing this powerful communication channel. Often, the inability to demonstrate return on investment prevents companies from pursuing more robust pharmaceutical digital marketing strategies. This study aims to solve that challenge for pharmaceutical executives with detailed benchmarks and analysis on ROI and ROE. The report examines the groups involved and the timelines necessary for companies to collect data and analyze initiatives’ ROI. It also includes best practices for combining formal ROI and ROE studies to connect return of pharmaceutical digital marketing initiatives to increased sales and achieve stakeholder buy-in.